There is an entire medical-industrial complex devoted to discovering and testing drugs to treat cardiovascular disease. Unfortunately there is a near complete absence of efforts to figure out if and when these same drugs should be discontinued. Consider Desmond Julian. The very distinguished cardiologist has been nearly killed by his profession on multiple occasions. In a State-of-the-Art…
Califf, Nissen, And Others Agree And Disagree About Regulatory Standards
September 1, 2015 by 1 Comment
Everyone agrees. A panel of US and European cardiologists, regulators, and industry executives agreed broadly that regulatory standards for drugs and devices need to be rigorous enough to prevent harm to patients. And, they also agreed, the standards shouldn’t be so strict that they stifle innovation. The problem, of course, is how to find the right…
Recent Comments